Medindia

X

Global Cold, Cough, and Sore Throat Remedies Industry

Wednesday, June 1, 2011 General News J E 4
Advertisement

NEW YORK, June 1, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Global Cold, Cough, And Sore Throat Remedies Industry

http://www.reportlinker.com/p0181103/Global-Cold-Cough-And-Sore-Throat-Remedies-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This report analyzes the worldwide markets for Cold, Cough, And Sore Throat Remedies in US$ Million. The report provides separate comprehensive analytics for US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. The report profiles 245 companies including many key and niche players worldwide such as Aaron Industries, Inc., AccuMed, Inc., Bayer Corporation, Biozone Laboratories, Inc., First Boston Pharma, LLC, GlaxoSmithKline Pharmaceuticals, Limited, G.R.Lane Health Products, Limited, Johnson & Johnson, Kalbe Farma Tbk, Matrixx Initiatives, Inc., Zicam, LLC, Nizhpharm OAO, Novartis AG, Perrigo Company, Pharmstandard Group, P. J. Noyes Company Inc., Procter & Gamble, Ranbaxy Laboratories Limited, Reckitt Benckiser Group plc, Schering-Plough Corporation, Taro Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Wyeth Consumer Healthcare. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

COLD, COUGH, AND SORE THROAT REMEDIES MCP-6151

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-3

Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

Introduction II-1

Demand and Sales Remain Cyclic and Seasonal II-1

Women & Kids - Primary Consumers of Cold and Cough Remedies II-2

FDA Discourages Use of Hydrocodone in Cough Medicines II-2

List of Antitussive Products (Containing Hydrocodone)

Approved by the USFDA as of 2008 II-2

OTC Medications for Children May Pose Health Risks II-3

Regulatory Agencies Revise OTC Drugs List II-3

CHPA Voluntarily Revises OTC Labels II-3

FDA Raises Red Flag for Acetaminophen II-3

OTC Drugs Move to Supermarkets II-3

Convenience Drives OTC Cold Cough Remedies Sales II-4

Delayed Winters Reduce Quarterly Revenues II-4

Key Growth Drivers II-4

Economic Slowdown II-4

Swine Flu II-4

The Need to Reduce Sick Leaves II-4

Growing Awareness about Rest Period II-4

OTC Industry - A Brief II-5

Table 1: World OTC Products Market (2008): Percentage

Breakdown of Retail Value Sales by Category - Analgesics,

Cold/Cough, Digestives, Vitamins, Minerals, and Supplements,

Skincare, and Others (includes corresponding Graph/Chart) II-5

Table 2: World Market for Nasal Congestion Products (2008):

Leading Players by Number of Marketed Products (includes

corresponding Graph/Chart) II-6

2. PRODUCT OVERVIEW II-7

Common cold II-7

Background and Etymology II-7

Common Cold Viruses II-7

Major Causes for Common Cold II-8

Symptoms of Common Cold II-8

Diagnosis II-9

Incubation Period and Disease Progression II-9

Common Cold- Affects on Other Body Parts II-10

Prevention of Common Cold II-10

Common Cold Remedies II-10

Effective Medications II-10

Zinc Lozenges II-11

Astragalus II-11

Pleconaril II-11

Limitations of Medications II-11

Antibiotics II-11

Antihistamines II-12

Over-the-Counter Medications II-12

Antihistamines II-12

Decongestants II-12

Pain Relievers II-13

Antitussives II-13

Expectorants II-13

Precautions Related with Common Cold Medicine II-13

Other Information II-14

Effective Home Remedies II-14

Cough II-17

Causes of Cough II-19

Symptoms and Diagnosis II-19

Physical Examination II-20

Testing II-20

Complications II-20

Cough Remedies II-20

Decongestants II-21

Expectorants and Suppressants II-21

Cough Suppressants II-21

Cough Expectorants II-21

Herbal Expectorants II-22

Corticosteroids II-22

Bronchodilators II-22

Nasal Corticosteroids II-23

Antihistamines II-23

Antitussive Agents II-23

Alternative Treatments and Supplementary Diets II-24

Other Alternative Treatments Based on Types of Cough II-26

Cough Caused Due to the Impairment of Internal Organs II-26

Attack of Sputum-Dampness on the Lungs II-26

Heat-Sputum in the lungs II-26

Attack of Liver-Fire on the Lungs II-27

Consumption of the lung-yin II-27

Cough caused due to the Invasion of Exogenous Pathogenic

Factors II-27

Wind Cold II-27

Wind-Heat II-27

Heat-Dryness II-27

Nagging Cough II-27

Symptoms II-28

Prevention/Solution II-28

Sore Throat II-28

Types of Sore Throats Based on Causes II-29

Viral Sore Throat II-30

Bacterial Sore Throat II-30

Noninfectious Sore Throat II-31

Sore Throat Due to Drug Interactions II-31

Other Causes II-31

Symptoms and Diagnosis II-31

Complications II-32

Medical Remedies II-32

Mitamins Advanced Formula (MAF) II-33

Carbimazole Drugs II-33

Antibiotics II-33

Other Drugs II-34

Alternative Treatments II-34

Homeopathy II-34

Home Remedies II-34

Common Home Remedies to Reduce Throat Pain II-37

Herbal Medicines II-38

Nutritional Therapy II-38

Ayurvedic Medicines II-38

Aromatherapy II-38

Other Sore Throat Therapies II-39

Common Drugs Used for Cold, Cough, and Sore Throat II-39

Evolution of Cold, Cough, & Sore Throat Remedies - A

Historic Review II-40

Cold Remedies- Drug/Treatment Option/ Product Name II-40

Cough Remedies - Drug/Treatment Option/Product Name II-41

Sore Throat Remedies - Drug/Treatment Option/Product Name II-41

Cold Cough and Sore Throat Symptoms & Treatment: A Special

Focus on Children II-41

Etiology of Cough in Children II-42

Whooping Cough in Children II-42

Risk Factors and Causes II-43

Symptoms II-43

Diagnosis and Treatment II-43

OTC Treatment Options II-43

Natural Health Remedies II-45

Prevention II-45

Treatment for Cough in Infants and Babies II-45

Whooping Cough Vaccines II-45

Treatment for Cough in Teenagers & Adults II-46

Alternative Medicines for Whooping Cough II-47

Therapeutic principles II-47

Syndrome Differentiation II-47

Classification and Treatment II-48

3. PRODUCT INNOVATIONS/INTRODUCTIONS II-49

Cadbury Launches HALLS Refresh II-49

McNeil Introduces ZYRTEC® Allergy Bubble Gum Syrup II-49

Honey, Don't Cough Introduces Children's Buckwheat Honey II-49

Honey Naturals to Launch ZarBee'sTM Children's Cough Syrup II-49

Hyland's Launches Cold Relief with Zinc 4 Kids II-49

Mach One Corporation Develops Swine Flu Virus Solution II-50

Schwabe Pharmaceuticals Unveils Zucol II-50

Schering-Plough Launches Afrin II-50

Auriga Introduces New Extendryl® Products II-50

Boiron Introduces Children's Coldcalm® and Children's

Oscillococcinum® II-51

Covidien Pharmaceutical Products Introduces TussiCaps® II-51

Hamdard Introduces Herbal Cough and Cold Medicines II-51

Insight Introduces Sucrets ICE II-51

Med-Systems Launches Pediatric Nasal Spray II-52

Health Care Products to Launch Nasal Ease Products II-52

Plethico Pharmaceuticals Introduces Travisil® II-52

St. Paul Brands Launches Fizzy Drink Remedy II-52

Oasis to Unveil Oasis Nasal Spray and Wash II-52

Auriga Laboratories Introduces Zinx Cold Relief Products II-53

Sanofi-Aventis Introduces Balsamic Decongestant Cream II-53

4. RECENT INDUSTRY ACTIVITY II-54

First Boston Pharma Acquires NutraMax Products II-54

FDA Halts Zicam Cold Remedy Sales II-54

Genomma Lab Takes Over Medicinas y Medicamentos Nacionales II-54

GSK Abandons Production of Actified II-54

Johnson & Johnson Acquires Cougar Biotechnology II-54

Laiyang Jiangbo Inks Purchase Agreement with Hongrui II-55

Lupin Acquires Rights for AllerNaze™ from Collegium

Pharmaceutical II-55

Pfizer Announces Plans to Take Over Wyeth II-55

Alcon Receives Approval for Patanase II-55

BHC Acquires Topsun (OTC) Cough and Cold Portfolio II-56

MiddleBrook Receives FDA Approval for MOXATAGTM Tablets II-56

Neuro-Hitech Acquires AMBI and MCR II-56

Perrigo Acquires Galpharm Healthcare II-56

Perrigo Acquires Distribution Rights for Levocetirizine II-57

Sun Pharma Receives FDA Approval for Generic Anti-Cough Drug II-57

Meda AB Acquires MedPointe, Inc. II-57

Reckitt Benckiser to Acquire Adams Respiratory Therapeutics II-57

5. FOCUS ON SELECT GLOBAL PLAYERS II-58

Aaron Industries, Inc. (US) II-58

AccuMed, Inc. (US) II-58

Bayer Corporation (US) II-58

Biozone Laboratories, Inc. (US) II-58

First Boston Pharma, LLC (US) II-59

GlaxoSmithKline Pharmaceuticals, Limited (India) II-59

G.R.Lane Health Products, Limited (UK) II-59

Johnson & Johnson (US) II-59

Kalbe Farma Tbk (Indonesia) II-59

Matrixx Initiatives, Inc. (US) II-60

Zicam, LLC (US) II-60

NIZHPHARM OAO (Russia) II-60

Novartis AG (Switzerland) II-60

Perrigo Company (US) II-61

Pharmstandard Group (Russia) II-61

P. J. Noyes Company Inc (US) II-61

Procter & Gamble (US) II-61

Ranbaxy Laboratories Limited (India) II-62

Reckitt Benckiser Group plc (UK) II-62

Schering-Plough Corporation (US) II-63

Taro Pharmaceuticals USA, Inc. (US) II-63

Teva Pharmaceutical Industries Ltd. (Israel) II-63

Thornton & Ross Ltd (UK) II-64

Wyeth Consumer Healthcare (US) II-64

6. GLOBAL MARKET PERSPECTIVE II-65

Table 3: World Recent Past, Current & Future Analysis for

Cold, Cough and Sore Throat Remedies by Geographic Region -

US, Canada, Japan, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for the Years 2006 through 2015 (includes

corresponding Graph/Chart) II-65

Table 4: World 9-Year Perspective for Cold, Cough and Sore

Throat Remedies by Geographic Region - Percentage Breakdown of

Dollar Sales for US, Canada, Japan, Europe, and Rest of World

Markets for the Years 2006, 2009 & 2015 (includes

corresponding Graph/Chart) II-66

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Outlook III-1

Overview III-1

OTC Sales Grow Despite Ongoing Debate Over Use in Children III-1

Private Labels Dominate III-1

OTC Products Market III-2

Table 5: US OTC Products Market (2008): Percentage

Breakdown of Retail Value Sales by Category - Cold and

Cough, Digestives, Internal Analgesics, Nutritional

Products, Topical Products, and Others (includes

corresponding Graph/Chart) III-2

Table 6: US OTC Products Market (2008): Percentage

Breakdown of Retail Value Sales by Leading Companies -

Bayer Group, GlaxoSmithKline, Johnson & Johnson, Procter &

Gamble, Wyeth, and Others (includes corresponding

Graph/Chart) III-2

Table 7: US OTC Products Market (2008): Percentage

Breakdown of Retail Value Sales by Outlet Type - Drug

Stores, Food Stores, Mass Merchandisers, and Others

(includes corresponding Graph/Chart) III-3

Major Brands III-3

Table 8: Leading Brands in the US Nasal Sprays/Inhalers/

Drops Market (2008): Percentage Breakdown of Retail Value

Sales by Brand - Afrin, Afrin No Drip, Ayr, Blairex Simply

Saline, NeilMed, Primatene Mist, SinuCleanse, Vicks, Vicks

Sinex, Zicam, and Others (includes corresponding

Graph/Chart) III-3

Table 9: Leading Brands in the US Nasal Sprays/Inhalers/

Drops Market (2008): Percentage Breakdown of Retail Volume

Sales by Brand - Afrin, Afrin No Drip, Ayr, Blairex Simply

Saline, NeilMed, Primatene Mist, SinuCleanse, Vicks, Vicks

Sinex, Zicam, and Others (includes corresponding

Graph/Chart) III-4

Table 10: Leading Brands in the US Cough/Cold - Chest Rubs

Market (2008): Percentage Breakdown of Retail Value Sales

by Brand - Little Colds, Mentholatum, Theraflu Vapor Patch,

Vicks Baby Rub, Vicks Casero, Vicks VapoRub, Private Label,

and Others (includes corresponding Graph/Chart) III-4

Table 11: Leading Brands in the US Cough/Cold - Chest Rubs

Market (2008): Percentage Breakdown of Retail Value Sales

by Brand - Little Colds, Mentholatum, Theraflu Vapor Patch,

Vicks Baby Rub, Vicks Casero, Vicks VapoRub, Private Label,

and Others (includes corresponding Graph/Chart) III-5

Table 12: Leading Brands in the US Cold/Allergy/Sinus

(Tablets/Packets) Market (2008): Percentage Breakdown of

Retail Value Sales by Brand - Airborne, Benadryl, Clarion

D, Claritin, Mucinex, Mucinex D, Mucinex DM, Sudafed PE,

Tylenol Cold, Zyrtec, Private Label, and Others (includes

corresponding Graph/Chart) III-5

Table 13: Leading Brands in the US Cold/Allergy/Sinus

(Tablets/Packets) Market (2008): Percentage Breakdown of

Retail Volume Sales by Brand - Airborne, Benadryl, Clarion

D, Claritin, Mucinex, Mucinex D, Mucinex DM, Sudafed PE,

Tylenol Cold, Zyrtec, Private Label, and Others (includes

corresponding Graph/Chart) III-6

Table 14: Leading Brands in the US Cold/Allergy/Sinus

(Liquid/Powder) Market (2008): Percentage Breakdown of

Retail Value Sales by Brand - Benadryl, Children's Tylenol,

Dimetapp, Robitussin, Robitussin CF, Theraflu, Triaminic,

Tylenol, Tylenol Cold, Vicks NyQuil, Private Label, and

Others (includes corresponding Graph/Chart) III-6

Table 15: Leading Brands in the US Cold/Allergy/Sinus

(Liquid/Powder) Market (2008): Percentage Breakdown of

Retail Volume Sales by Brand - Benadryl, Children's

Tylenol, Dimetapp, Robitussin, Robitussin CF, Theraflu,

Triaminic, Tylenol, Tylenol Cold, Vicks NyQuil, Private

Label, and Others (includes corresponding Graph/Chart) III-7

Table 16: Leading Brands in the US Cough Syrup/Sore Throat

Remedy Liquids Market (2008): Percentage Breakdown of

Retail Value Sales by Brand - Airborne, Benadryl, Clarion

D, Claritin, Mucinex, Mucinex D, Mucinex DM, Sudafed PE,

Tylenol Cold, Zyrtec, Private Label, and Others (includes

corresponding Graph/Chart) III-7

Table 17: Leading Brands in the US Cough Syrup/Sore Throat

Remedy Liquids Market (2008): Percentage Breakdown of

Retail Volume Sales by Brand - Chloraseptic Sore Throat

Remedy, Delsym Cough Syrup, Diabetic Tussin Cough Syrup,

Robitussin Cough Syrup, Private Label, and Others (includes

corresponding Graph/Chart) III-8

Table 18: Leading Brands in the US Nasal Aspirators Market

(2008): Percentage Breakdown of Retail Value Sales by Brand

- Cara, First Years, Gerber, Luv N Care Nuby, Ross,

Sunmark, Private Label, and Others includes corresponding

Graph/Chart) III-8

Table 19: Leading Brands in the US Nasal Aspirators Market

(2008): Percentage Breakdown of Retail Volume Sales by

Brand - Cara, First Years, Gerber, Luv N Care Nuby, Ross,

Sunmark, Private Label, and Others (includes corresponding

Graph/Chart) III-9

Table 20: Leading Brands in the US Nasal Sprays Market

(2008): Percentage Breakdown of Retail Volume Sales by

Brand - Afrin, Afrin No Drip, Primatene Mist, Vicks Sinex,

Zicam, and Others (includes corresponding Graph/Chart) III-9

Table 21: Leading Brands in the US Internal Analgesic

Liquids Market (2007): Percentage Breakdown of Retail Value

Sales by Brand - Children's Advil, Children's Motrin,

Children's Tylenol, Infants' Advil, Infants' Motrin,

Motrin, Tylenol, Tylenol Flavor Creator, Tylenol PM,

Private Label, and Others (includes corresponding

Graph/Chart) III-10

Table 22: Leading Brands in the US Internal Analgesic

Liquids Market (2007): Percentage Breakdown of Retail

Volume Sales by Brand -Children's Advil, Children's Motrin,

Children's Tylenol, Gel Stat, Infants' Advil, Infants'

Motrin, Motrin, Tylenol, Tylenol Flavor Creator, Tylenol

PM, Private Label, and Others (includes corresponding

Graph/Chart) III-10

Select Intranasal Antihistamines, Oral OTC Antihistamines,

and Intranasal Corticosteroids in the US Market, as of

2008 III-11

Product Launches III-11

Strategic Corporate Developments III-14

Key Players III-16

B.Market Analytics III-20

Table 23: The US Recent Past, Current & Future Analysis for

Cold, Cough and Sore Throat Remedies - Annual Sales Figures

in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-20

2. CANADA III-21

A.Market Analysis III-21

Outlook III-21

OTC Products Market III-21

Table 24: Canadian OTC Products Market (2006): Percentage

Breakdown of Retail Value Sales by Category - Analgesics,

Cold and Cough, Digestives, Nutritional Products, and

Others (includes corresponding Graph/Chart) III-21

Table 25: Canadian OTC Products Market (2006): Percentage

Breakdown of Retail Value Sales by Outlet Type - Mass

Merchandisers, Food Stores, Drug Stores, and Others

(includes corresponding Graph/Chart) III-21

Table 26: Canadian OTC Products Market (2006): Percentage

Breakdown of Retail Value Sales by Leading Companies -

Bayer Group, Jamieson Laboratories, Johnson & Johnson,

Perrigo, Wyeth, and Others (includes corresponding

Graph/Chart) III-22

B.Market Analytics III-22

Table 27: Canadian Recent Past, Current & Future Analysis

for Cold, Cough and Sore Throat Remedies - Annual Sales

Figures in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-22

3. JAPAN III-23

A.Market Analysis III-23

Outlook III-23

OTC Drugs Market III-23

Pharmaceutical Affairs Law III-23

B.Market Analytics III-24

Table 28: Japanese Recent Past, Current & Future Analysis

for Cold, Cough and Sore Throat Remedies - Annual Sales

Figures in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-24

4. EUROPE III-25

A.Market Analysis III-25

Outlook III-25

Overview III-25

Innovative Packaging Induces Growth III-25

OTC Markets Espouse FMCG Market Features III-25

Market Snippets III-26

B.Market Analytics III-26

Table 29: European Recent Past, Current & Future Analysis

for Cold, Cough and Sore Throat Remedies by Geographic

Region - France, Germany, Italy, Spain, UK, and Rest of

Europe Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-26

Table 30: European 9-Year Perspective for Cold, Cough and

Sore Throat Remedies by Geographic Region - Percentage

Breakdown of Dollar Sales for France, Germany, Italy, Spain,

UK, and Rest of Europe Markets for the Years 2006, 2009 &

2015 (includes corresponding Graph/Chart) III-27

4a. FRANCE III-28

A.Market Analysis III-28

Outlook III-28

Overview III-28

B.Market Analytics III-29

Table 31: French Recent Past, Current & Future Analysis for

Cold, Cough and Sore Throat Remedies - Annual Sales Figures

in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-29

4b. GERMANY III-30

A.Market Analysis III-30

Outlook III-30

Overview III-30

B.Market Analytics III-31

Table 32: German Recent Past, Current & Future Analysis for

Cold, Cough and Sore Throat Remedies - Annual Sales Figures

in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-31

4c. ITALY III-32

A.Market Analysis III-32

Outlook III-32

Overview III-32

B.Market Analytics III-32

Table 33: Italian Recent Past, Current & Future Analysis for

Cold, Cough and Throat Remedies - Annual Sales Figures in

US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-32

4d. THE UNITED KINGDOM III-33

A.Market Analysis III-33

Outlook III-33

Overview III-33

Table 34: The UK Market for Cold and Flu Remedies (2008):

Percentage Breakdown of Retail Value Sales by Major Brands

-Beechams, Benylin, Lemsip, Nurofen Cold and Flu, Nurses,

Private Label, and Others (includes corresponding

Graph/Chart) III-34

Strategic Corporate Developments III-34

Key Players III-35

B.Market Analytics III-36

Table 35: The UK Recent Past, Current & Future Analysis for

Cold, Cough and Sore Throat Remedies - Annual Sales Figures

in US$ Million for Years 2006 through 2015 (includes

corresponding Graph/Chart) III-36

4e. SPAIN III-37

A.Market Analysis III-37

Outlook III-37

Overview III-37

B.Market Analytics III-38

Table 36: Spanish Recent Past, Current & Future Analysis

for Cold, Cough and Sore Throat Remedies - Annual Sales

Figures in US$ Million for Years 2006 through 2015

(includes corresponding Graph/Chart) III-38

4f. REST OF EUROPE III-39

A.Market Analysis III-39

Outlook III-39

Product Launches III-39

Strategic Corporate Developments III-40

Key Players III-40

B.Market Analytics III-41

Table 37: Rest of Europe Recent Past, Current & Future

Analysis for Cold, Cough and Sore Throat Remedies - Annual

Sales Figures in US$ Million for Years 2006 through 2015

(includes corresponding Graph/Chart) III-41

5. REST OF WORLD III-42

A.Market Analysis III-42

Outlook III-42

Peek into Select Markets III-42

Indian Market Overview III-42

Shift from Rx to OTC: Viable Solution for Off-Patent

Products III-42

Complete Conversion of Rx to OTC is Unfeasible III-42

OTC Retail III-43

Impelling Factors III-43

Impeding Factors III-43

Economic Slowdown Disturbs Pharma Industry Growth III-43

Chinese Market Overview III-43

OTC Drugs Market Gains Momentum III-44

Peruvian Market Overview III-44

Product Launches III-44

Strategic Corporate Developments III-45

Key Players III-46

B.Market Analytics III-48

Table 38: Rest of World Recent Past, Current & Future

Analysis for Cold, Cough and Sore Throat Remedies - Annual

Sales Figures in US$ Million for Years 2006 through 2015

(includes corresponding Graph/Chart) III-48

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 223 (including Divisions/Subsidiaries - 245)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 45

Canada 2

Japan 3

Europe 63

France 6

Germany 16

The United Kingdom 9

Italy 6

Spain 1

Rest of Europe 25

Asia-Pacific (Excluding Japan) 115

Latin America 3

Middle-East 14

------------------------------------------

To order this report:

Pharmaceutical Industry: Global Cold, Cough, And Sore Throat Remedies Industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Human Papillomavirus (HPV) Thera...
S
Reportlinker Adds Testicular Cancer Therapeutics -...